You're seeing this page as if you were . The main menu is still yours, though. Exit from immersion

About Christoph

I help companies accelerate revenue, fix commercial execution, and scale internationally.

With 20+ years of experience across Europe, China, and LATAM, I’ve built and transformed commercial organizations in MedTech, healthcare, and B2B technology—always with a clear focus on results.

I typically step in when:

growth stalls or needs acceleration

commercial structures don’t scale

international expansion becomes critical

leadership or transformation is required

What sets me apart: strategy + execution.
I don’t just define direction & implement it.

Selected impact:

+34% revenue growth in MedTech

Distributor networks across 28+ markets

€5M+ funding supported through commercial positioning

Built businesses from €0 to €12M+ in 2 years (double-digit EBIT)
  • German

    Native or bilingual

  • English

    Native or bilingual

  • Italian

    Conversational

  • Chinese

    Conversational

Can work on-site
Munich (up to 50km)

Experience

  • OligoScience Biotechnology
    Fractional Chief Commercial Officer
    January 2023 - October 2025 (2 years and 9 months)
    48 Münster, Germany
    • • The Challenge: Deep-tech biotech scale-up with strong science but no commercial function, no GTM strategy, and no investor narrative.
    • • My Role (Fractional CCO): Built the complete commercial organization from the ground up over 24 months.
    • • Key Deliverables:
    ◦ o Developed global go-to-market strategy, brand positioning, and pricing model
    ◦ o Crafted investor-ready narrative, led data room preparation, and supported fundraising
    ◦ o Secured €5.3M growth funding (€1.8M public, €3.5M private)
    ◦ o Established marketing, sales, strategic partnerships, and investor relations functions
    ◦ o Aligned R&D output with market demand for scalable commercialization
  • SIC invent Group (Dental Technology)
    Interim General Manager & Board Member
    August 2019 - October 2022 (3 years and 2 months)
    Real Shanghai Cafe & Bar, Shanghai, China
    • • The Challenge: International MedTech company with flat revenue, inefficient operations, and no scalable commercial infrastructure.
    • • My Role (Interim GM): Full P&L responsibility, Board-level strategic oversight, and team leadership.
    • • Key Deliverables:
    ◦ o Delivered +34% revenue growth (€6.8M → €9.1 M) while restoring profitability
    ◦ o Expanded distributor network to 28 countries, enabling global scaling
    ◦ o Implemented Salesforce CRM and ERP systems for performance transparency
    ◦ o Designed and deployed digital KOL education platform engaging 5,000+ dental professionals
    ◦ o Executed full global rebrand and strengthened corporate governance
    ◦ o Maintained 0% staff turnover during transformation
  • AKKA Technologies Consulting (now Akkodis)
    Interim Consulting Director & Strategic Advisor
    October 2016 - July 2019 (2 years and 9 months)
    Beijing, China
    • • The Challenge: Complex matrix environment with 13 brands requiring digital transformation and strategic alignment.
    • • My Role: Strategic advisor and de-facto Transformation Office (PMO) lead.
    • • Key Deliverables:
    ◦ o Guided C-suite clients through digital transformation and strategy programs
    ◦ o Orchestrated VW Group China HQ relocation (1,200 employees) with agile collaboration models
    ◦ o Shifted consulting model from body-leasing to value-based engagements
    ◦ o Drove +50% profitability growth from VW Group account through portfolio governance

Recommendations

Be the first to recommend Christoph

Help this freelancer shine by sharing your experience working together.

These freelancer profiles also match your criteria

AgathaA

Agatha Frydrych

Backend Java Software Engineer

4.7

(3)

2

BaptisteB

Baptiste Duhen

Fullstack developer

4.6

(4)

5

AmedA

Amed Hamou

Senior Lead Developer

4

(2)

7

AudreyA

Audrey Champion

Web developer

4.3

(3)

4

Education

  • Leading from the Emerging Future
    Massachusetts Institute of Technology (MIT)
    2025
    Leading from the Emerging Future
  • Designing Resilient Regenerative Systems
    ETH Zürich
    2024
    Designing Resilient Regenerative Systems

Categories